WO2000002874A3 - Integrin dependent cell adhesion inhibitors - Google Patents
Integrin dependent cell adhesion inhibitors Download PDFInfo
- Publication number
- WO2000002874A3 WO2000002874A3 PCT/GB1999/002219 GB9902219W WO0002874A3 WO 2000002874 A3 WO2000002874 A3 WO 2000002874A3 GB 9902219 W GB9902219 W GB 9902219W WO 0002874 A3 WO0002874 A3 WO 0002874A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell adhesion
- dependent cell
- adhesion inhibitors
- integrin dependent
- integrin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to euparin derivatives having broad spectrum integrin receptor inhibition activity and utility in the treatment of integrin mediated disease.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9814801.8A GB9814801D0 (en) | 1998-07-09 | 1998-07-09 | Integrin dependent cell adhesion inhibitors |
GB9814801.8 | 1998-07-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000002874A2 WO2000002874A2 (en) | 2000-01-20 |
WO2000002874A3 true WO2000002874A3 (en) | 2000-02-24 |
Family
ID=10835162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1999/002219 WO2000002874A2 (en) | 1998-07-09 | 1999-07-09 | Integrin dependent cell adhesion inhibitors |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB9814801D0 (en) |
WO (1) | WO2000002874A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002243692B2 (en) | 2001-01-29 | 2006-06-08 | 3-Dimensional Pharmaceuticals, Inc. | Substituted indoles and their use as integrin antagonists |
US6872730B2 (en) | 2001-04-27 | 2005-03-29 | 3-Dimensional Pharmaceuticals, Inc. | Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
CN104095840B (en) * | 2014-06-23 | 2016-04-27 | 西安交通大学 | The application of euparin in preparation treatment ischemic cardio cerebrovascular diseases medicine |
CN105919991B (en) * | 2016-05-18 | 2019-01-15 | 西安交通大学 | Application of the euparin in preparation medicament for treatment of depression |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0132130A2 (en) * | 1983-07-14 | 1985-01-23 | Syntex (U.S.A.) Inc. | Aroyl benzofuran and benzothiophene acetic and propionic acids processes for their production and pharmaceutical compositions containing them |
WO1998009956A1 (en) * | 1996-09-09 | 1998-03-12 | Dainippon Pharmaceutical Co., Ltd. | 2,3-dihydrobenzofuran derivative and hepatopathy remedy comprising the same as active ingredient |
WO1998014440A1 (en) * | 1996-10-04 | 1998-04-09 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
-
1998
- 1998-07-09 GB GBGB9814801.8A patent/GB9814801D0/en not_active Ceased
-
1999
- 1999-07-09 WO PCT/GB1999/002219 patent/WO2000002874A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0132130A2 (en) * | 1983-07-14 | 1985-01-23 | Syntex (U.S.A.) Inc. | Aroyl benzofuran and benzothiophene acetic and propionic acids processes for their production and pharmaceutical compositions containing them |
WO1998009956A1 (en) * | 1996-09-09 | 1998-03-12 | Dainippon Pharmaceutical Co., Ltd. | 2,3-dihydrobenzofuran derivative and hepatopathy remedy comprising the same as active ingredient |
WO1998014440A1 (en) * | 1996-10-04 | 1998-04-09 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
Also Published As
Publication number | Publication date |
---|---|
GB9814801D0 (en) | 1998-09-09 |
WO2000002874A2 (en) | 2000-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1044545A1 (en) | Human beta-secretase enzyme, inhibitors and their compositions and uses | |
AU2018301A (en) | Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases | |
AU2687301A (en) | Novel glycosidase inhibitors and their pharmacological uses, in particular for treating diabetes | |
AU7620200A (en) | Compositions and methods relating to the inhibition of casomorphin and gluteomorphin | |
MY135732A (en) | 5,6-trimethylenepyrimidin - 4 - one compounds | |
EP1115389A4 (en) | Fructosamine oxidase: antagonists and inhibitors | |
AU3478100A (en) | Rapid determination of present and potential battery capacity | |
AU5264599A (en) | Thiocarboxamide derivatives and their use as inhibitors of alpha-4 integrins | |
WO2000071703A3 (en) | Inhibition of histone deacetylase | |
AU1853600A (en) | Method for the detection of gene transcripts in blood and uses thereof | |
HUP9800634A3 (en) | P-amidino-benzylamide derivatives as thrombin inhibitors, intermediates and use thereof | |
AU6909300A (en) | Substituted ureas as cell adhesion inhibitors | |
AU2002223647A1 (en) | Aryl-substituted indirubin derivatives, the production thereof and use of the same | |
AU2208401A (en) | Inhibitors of complement activation, their preparation and use | |
HK1022419A1 (en) | Agent for inhibition of cytokine production and agent for inhibition of cell adhesion. | |
AU3716499A (en) | Substituted diamines and their use as cell adhesion inhibitors | |
HK1041006A1 (en) | Derivatives of monosaccharides as cell adhesion inhibitors. | |
EP1185555A4 (en) | Compositions isolated from skin cells and methods for their use | |
AU1028601A (en) | Isoquinoline and quinazoline derivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity | |
AU4501199A (en) | 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors | |
DE60005300D1 (en) | 2,3-O-ISOPROYLIDENE DERIVATIVES OF MONOSACCHARIDES AND USE AS CELL ADHESION INHIBITORS | |
PL353214A1 (en) | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors | |
WO2000002874A3 (en) | Integrin dependent cell adhesion inhibitors | |
AU6500600A (en) | Methods and compositions for determining enzymatic activity | |
AU5680900A (en) | Combination of mtp inhibitors and hmg-coa reductase inhibitors and the use thereof in medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase |